Page last updated: 2024-10-21

1-hydroxy-3-amino-2-pyrrolidone and Acquired Metabolic Diseases, Brain

1-hydroxy-3-amino-2-pyrrolidone has been researched along with Acquired Metabolic Diseases, Brain in 1 studies

1-hydroxy-3-amino-2-pyrrolidone: a CNS depressant; structure in first source

Research Excerpts

ExcerptRelevanceReference
"Coma and convulsions develop in neonates in typical GE while psychomotor retardation and behavioral abnormalities in infancy and childhood are observed in mild GE."1.35Model mice for mild-form glycine encephalopathy: behavioral and biochemical characterizations and efficacy of antagonists for the glycine binding site of N-methyl D-aspartate receptor. ( Aoki, Y; Ichinohe, A; Kamada, F; Kanno, J; Kojima-ishii, K; Komatsuzaki, S; Kure, S; Matsubara, Y; Mizoi, K; Nakahara, D; Narisawa, A; Oda, M; Shinka, T; Sugawara, T; Yokoyama, H, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kojima-ishii, K1
Kure, S1
Ichinohe, A1
Shinka, T1
Narisawa, A1
Komatsuzaki, S1
Kanno, J1
Kamada, F1
Aoki, Y1
Yokoyama, H1
Oda, M1
Sugawara, T1
Mizoi, K1
Nakahara, D1
Matsubara, Y1

Other Studies

1 other study available for 1-hydroxy-3-amino-2-pyrrolidone and Acquired Metabolic Diseases, Brain

ArticleYear
Model mice for mild-form glycine encephalopathy: behavioral and biochemical characterizations and efficacy of antagonists for the glycine binding site of N-methyl D-aspartate receptor.
    Pediatric research, 2008, Volume: 64, Issue:3

    Topics: Aggression; Amino Acid Oxidoreductases; Animals; Anxiety; Binding Sites; Brain Diseases, Metabolic;

2008